Sanjay Kedhar, M.D.
NPI 1700833951ActiveIndividual· Ophthalmology, Uveitis and Ocular Inflammatory Disease· Irvine, CA
Ophthalmology, Uveitis and Ocular Inflammatory Disease (M.D.) in Irvine, California, trained at New York Medical College (class of 1999). Their prescriptions cost Medicare Part D more than their services did: $549,991 for 1,465 claims, against $203,113 paid for services in 2024. Ani Pharmaceuticals, Inc. was the largest of 4 companies reporting payments in 2025, $55,894 in all, mostly honoraria.
Overview
| NPI | 1700833951 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | May 30, 2006 |
| Last updated in NPPES | Feb 25, 2025 |
| Certified by provider | Feb 25, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Ophthalmology, Uveitis and Ocular Inflammatory Disease Primary | 207WX0108X | C141299 | CA |
| Ophthalmology | 207W00000X | D60540 | MD |
| Ophthalmology, Uveitis and Ocular Inflammatory Disease | 207WX0108X | 141299 | CA |
| Ophthalmology, Cornea and External Diseases Specialist | 207WX0120X | 141299 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Ophthalmology (CA); Practitioner - Ophthalmology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 540 |
|---|---|
| Services billed | 2,044 across 53 procedure codes |
| Paid by Medicare | $203,113 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,465 · 2,099 30-day fills |
|---|---|
| Patients | 322 |
| Total drug cost | $549,991 |
| Generic share | 47% of claims |
Education and affiliations
| Medical school | New York Medical College |
|---|---|
| Graduation year | 1999 |
| Medicare specialty | Ophthalmology |
Medical group
- Regents of the University of CaliforniaOrange, CA · 54 clinicians
Hospital affiliations
- Hoag Memorial Hospital PresbyterianNewport Beach, CA
- Uci Health-OrangeOrange, CA
Industry payments (Open Payments)
- 2025$55,894 · 43 payments from 4 companies
- 2024$14,375 · 15 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Ani Pharmaceuticals, Inc. | $55,617 | 40 |
| Biotissue Holdings Inc. | $134.42 | 1 |
| Bausch & Lomb Americas Inc. | $113.23 | 1 |
| Dompe US, Inc. | $29.22 | 1 |
What the 2025 payments were for
- Honoraria$48,525 · 10 payments
- Travel and Lodging$5,965 · 17 payments
- Food and Beverage$1,403 · 16 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Ophthalmology, Uveitis and Ocular Inflammatory Disease providers in Irvine
- 1134279995
All Ophthalmology, Uveitis and Ocular Inflammatory Disease providers in California →